Literature DB >> 8738814

Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics.

T A Depner1, J T Daugirdas.   

Abstract

The normalized protein catabolic rate (PCRn) can be calculated from predialysis and postdialysis BUN measurements in patients receiving intermittent dialysis. This measure of net protein catabolism, adjusted for body size, is a useful clinical measure of nutrition that correlates with patient outcome and, in patients who are in nitrogen balance, is a reasonable estimate of dietary protein intake. Whereas simplified formulae that estimate the per-treatment dose of hemodialysis, expressed as Kt/Vurea (Kt/V), are in common use, simplified methods for determining PCRn have only recently appeared. In the study presented here, equations were derived for calculating PCRn from the predialysis BUN and Kt/V. The equations were of the general form: PCRn = C0/(a + bKt/V + c/(Kt/NLL)) + 0.168, where Co is the predialysis BUN in mg/dL. Three sets of coefficients were developed for patients dialyzed thrice weekly: one for patients dialyzed after the long interval at the beginning of the week, one for patients dialyzed at midweek, and the third for patients dialyzed at the end of the week. Two similar sets of coefficients were developed for patients dialyzed twice weekly. For patients with remaining function in the native kidney remnant, equations were developed and refined for upgrading PCRn by adjusting C0 upward. The equations were validated by comparing the calculated PCRn with PCRn determined by a formal iterative model of urea kinetics in a series of 119 dialyses in 51 patients dialyzed thrice weekly (r = 0.9952; mean absolute error, 1.97 +/- 1.39%) and in a series of 71 dialyses in 25 patients dialyzed twice weekly (r = 0.9956; mean absolute error, 2.17 +/- 1.56%). These simple yet accurate equations should be useful in epidemiologic studies or in clinical laboratories where limited data are available for each patient or when iterative computer techniques cannot be applied.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738814     DOI: 10.1681/ASN.V75780

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

1.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients.

Authors:  Yoshitsugu Obi; Connie M Rhee; Anna T Mathew; Gaurang Shah; Elani Streja; Steven M Brunelli; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2016-05-11       Impact factor: 10.121

3.  Two-point normalized protein catabolic rate overestimates nPCR in pediatric hemodialysis patients.

Authors:  Poyyapakkam R Srivaths; Scott Sutherland; Steven Alexander; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2012-12-02       Impact factor: 3.714

4.  The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis.

Authors:  Francesco Gaetano Casino; Salvatore Domenico Mostacci; Andrea Sabato; Manuela Montemurro; Clelia Procida; Angelo Saracino; Giovanni Santarsia; Carlo Basile
Journal:  J Nephrol       Date:  2020-10-27       Impact factor: 3.902

5.  Association of Parameters of Mineral Bone Disorder with Mortality in Patients on Hemodialysis according to Level of Residual Kidney Function.

Authors:  Mengjing Wang; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Wei Ling Lau; Jing Chen; Chuanming Hao; Takayuki Hamano; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-09       Impact factor: 8.237

6.  Ultrafiltration Rate, Residual Kidney Function, and Survival Among Patients Treated With Reduced-Frequency Hemodialysis.

Authors:  Yu-Ji Lee; Yusuke Okuda; John Sy; Yong Kyu Lee; Yoshitsugu Obi; Seong Cho; Joline L T Chen; Anna Jin; Connie M Rhee; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Am J Kidney Dis       Date:  2019-12-06       Impact factor: 8.860

7.  Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemodialysis patients.

Authors:  Ilia Beberashvili; Ada Azar; Inna Sinuani; Hadas Kadoshi; Gregory Shapiro; Leonid Feldman; Zhan Averbukh; Joshua Weissgarten
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

8.  Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Authors:  Xue-Sen Cao; Jun Chen; Jian-Zhou Zou; Yi-Hong Zhong; Jie Teng; Jun Ji; Zhang-Wei Chen; Zhong-Hua Liu; Bo Shen; Yu-Xin Nie; Wen-Lv Lv; Fang-Fang Xiang; Xiao Tan; Xiao-Qiang Ding
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

9.  Impact of residual kidney function on hemodialysis adequacy and patient survival.

Authors:  Mengjing Wang; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Jing Chen; Chuanming Hao; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

10.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.